The mainstays of medical management of PD include levodopa and dopamine receptor agonists. 5 However, disease progression is associated with the temporal shortening of medication response and drug-related involuntary movements, with approximately 40% of PD patients developing dyskinesias and motor fluctuations 4 to 6 yr after levodopa treatment. 6, 7 Deep brain stimulation (DBS) has become an important component in the long-term management of several neurological and psychiatric disorders, including for those with PD who have nonresponsive motor fluctuations or debilitating tremor. 8 After originally being approved by the FDA for the treatment of essential tremor in 1997, DBS subsequently received FDA approval for PD in 2002. 9 It has also been approved for the treatment of dystonia and is currently being studied as a potential treatment option in obsessive-compulsive disorder, depression, and obesity. [9] [10] [11] [12] Multiple randomized clinical trials have shown DBS to be more effective than the best medical management in selected patients with PD in sustaining improvement in motor symptoms, activities of daily living, and quality of life. [13] [14] [15] [16] [17] [18] DBS treatment requires extensive preoperative testing and frequent outpatient visits. These requirements, along with significant outof-pocket costs, may limit access to DBS for lowincome patients or patients living in medically disadvantaged areas. 8, 19 Additionally, elderly patients with PD are not well represented in DBS clinical trials, and physicians may elect to preferentially perform DBS on younger, healthier ABBREVIATIONS: CCI, Charlson Comorbidity Index; CI, confidence interval; DBS, deep brain stimulation; OR, odds ratio; PD, Parkinson Disease patients. 8, 17, 20 This disparity in age representation is especially important to consider given the advanced age of PD onset (averaging approximately 60 yr old) and the reported findings that earlier surgical intervention with DBS is associated with improved quality of life. 16, 21 As an increasing number of studies have demonstrated the benefit of early DBS in patients with PD, it is important to determine whether physician practice has changed to reflect new clinical understanding. Furthermore, physicians should be made aware of whether trends in treatment allocation in the United States depend on demographic factors or on the type of hospital providing treatment. We performed a DBS utilization study of 216 759 hospitalizations in the United States in patients with PD between 2000 and 2011. We provide data demonstrating shifts in DBS utilization in the management of PD. We additionally sought to identify demographic and system-level factors that influenced these changes and independently contributed to the probability of a patient with PD receiving DBS. To our knowledge, this is the first study analyzing temporal trends in the use of DBS based on these variables.
METHODS
We retrospectively analyzed the Nationwide Inpatient Sample database (NIS) from 2000 to 2011 of patients admitted to hospitals in the United States with a diagnosis of PD. Institutional review board approval was not required for this study using a publicly available, national database of anonymous patients. The NIS database, gathered by the Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, provides a stratified sample of all patient discharges from approximately 20% of nonfederal hospitals in the United States between 2000 and 2011. 22 We included PD patients who were admitted for any reason, as PD patients are most often hospitalized for comorbid diseases and not expressly for PD. 23 The International Classification of Diseases, Ninth Revision (ICD-9) code used to identify discharged patients with Primary Idiopathic PD diagnosis was 332.0 and the ICD-9 code used to identify discharged patients having received the DBS procedure was 2.93. Procedures with no associated PD primary diagnosis code were excluded.
We examined the trends in patient-and hospital-based variables in PD patients receiving DBS and those who were admitted for another reason. Patient demographic and experience variables examined included age, race, gender, Charlson Comorbidity Index (CCI) score, payment type, admission source, admission type, discharge status, and length of stay. 24 The categories for race provided by the NIS were "white," "black," "Hispanic," "Asian/Pacific Islander," "Native American," and "other." In this paper, we refer to the "black" categorization as "African-American." Hospital-based variables that were tracked included hospital bed size (small, medium, large), hospital region (Northeast, Midwest, South, West), whether the hospital was considered teaching or nonteaching, and whether the hospital was considered rural or urban. Details of the other categories used by the NIS for stratification of each variable are outlined elsewhere. 25, 26 We followed the HCUP guideline for the data analysis (https://www.hcup-us. ahrq.gov/tech_assist/tutorials.jsp). The study qualified for institutional review board waiver. SAS R 9.4 (SAS Institute, Cary, North Carolina) was used for all data analysis. We used the SAS SURVEYMEANS procedure to take account of survey weight and obtain the nationwide estimation for percentage of patient who received DBS. The trend (absolute change/year) of DBS utilization rate from 2000 to 2011 was estimated using additive Poisson regression with generalized estimating equation to account for nested data structure of patient and hospital. Interaction test was used to assess the difference in year trend across patient characteristics (e.g., male vs female) or hospital characteristics (e.g., teaching vs nonteaching hospitals).
Notably, the NIS database reported that some DBS procedures were performed "emergently," as reported below; this was deemed an inherent limitation with the database, as it is very unlikely that the DBS procedure was truly performed emergently.
RESULTS
Query of the NIS yielded 216 759 discharges for PD between 2000 and 2011, with 26 415 hospitalizations for the DBS procedure. The total number of DBS operations performed in the United States increased from 1276 to 3474 operations ( Figure 1A) . The percent of all admissions for DBS increased from 6.3% to 20.8% in the same time span ( Figure 1B) .
The total number of PD patients admitted for DBS or for any other reason between 2000 and 2011 were stratified according to demographic and hospital characteristic variables (Tables 1  and 2 ). Missing data did not account for a significant proportion of each stratification variable except for admission source and admission type. The majority (55.6%) of patients receiving DBS were between the ages of 60 and 74 yr old. Only 3.7% of DBS procedures were performed on those under the age of 45, and only 3.1% were performed on patients 80 yr or older, despite patients 80 yr or older composing 34.3% of all PD admissions ( Figure 2 ). No clinically significant trends were found between 2000 and 2011 in the proportion of patients who received DBS from each age group. However, discrepancies between the age groups were observed when trending the proportion of PD admissions that were admitted for DBS ( Figure 3 ). The proportion of PD admissions receiving DBS increased more dramatically for patients between 35 and 74 yr old (14.7% in 2000 to 40.6% in 2011) than for those over 75 yr old (1.4% to 6.0%). The trend in the proportion of PD admissions for DBS in patients under 35 yr old was highly variable due to small sample size. Patients between 35 and 74 were significantly more likely to be admitted for DBS than patients over the age of 75 yr (odds ratio [OR] 10.8, 95% confidence interval [CI] 10.4-11.2, P < .001).
The majority of DBS procedures (68.6%) were performed on patients identifying as white. The increase in the proportion of PD admissions for DBS was less dramatic for African Americans (0% in 2000 to 6.8% in 2011) than for Whites (7.3%-25.8%), Hispanics (4.9%-29.0%), and Asian/Pacific Americans (8.8%-35.0%; Figure 4 ). Overall, African-Americans admitted with PD were significantly less likely to receive DBS compared to other races (Rate Ratio [OR] 0.16, 95% CI 0.14-0.18, P < .001).
A larger proportion of DBS procedures were performed on males (67.4% of operations) compared to females (31.1%, P < .001). Overall, 17 801 of 95 447 male patients (18.7%) received DBS, while 8207 of 67 550 female patients (12.1%) received DBS. The proportion of PD admissions for DBS increased relatively consistently for both males (8.5% in 2000 to 27.9% in 2011) and females (4.9%-20.0%; Figure 5 ). Female PD patients were less likely to receive DBS compared to male PD patients (OR 0.65, 95% CI 0.63-0.67, P < .001).
The CCI is a widely used prognostic tool that uses comorbid conditions to predict 1-yr all-cause mortality of admitted patients. 24 Each comorbid condition is assigned a score of 1, 2, 3, or 6 depending on the associated risk of mortality. Higher scores are associated with increased mortality. The clear majority of PD patients receiving DBS had a CCI score of 0 (96.7%). However, the proportion of admitted patients receiving DBS with a CCI score of 1 or greater increased between 2000 and 2011 ( Figure 6 ). The proportion of admitted patients with PD receiving DBS with a CCI score between 1 and 2 increased from 0.8% in 2000 to 7.0% in 2011, and the proportion of patients receiving DBS with a CCI score of 3 or greater increased from 0.4% to 3.8% in the same time frame.
For PD patients receiving DBS, 62.6% of patients used Medicare and 32.7% used private insurance (including health maintenance organization (HMO)). Only 2.1% of patients used Medicaid and only 0.5% of patients paid for their own treatment completely out of pocket. No clear trend in the frequency of payment type between 2000 and 2011 was observed ( Figure 7A ). The percent of PD patients receiving DBS increased between 2000 and 2011 for patients using private insurance, Medicaid, and Medicare, but the proportion of patients receiving DBS was consistently highest for those with private insurance ( Figure 7B ).
Most PD patients receiving DBS were categorized under a routine admission source (65.5%) and had the procedure done electively (75.8%). Only 2.6% had DBS performed urgently and 1.5% had the procedure performed emergently. Only 0.2% of admissions for DBS (51 patients) died in the hospital before discharge, compared to 1.7% of patients dying in the hospital when discharged for a reason other than DBS. Most patients receiving DBS were discharged routinely (87.6%), whereas patients admitted for another reason were only discharged routinely 23.7% of the time. Compared to 12.0% of DBS patients transferred to another facility (either to home health care or to another location, such as a skilled nursing facility), 58.2% of patients admitted for another reason were transferred to another facility ( Figure 8 ).
The majority of DBS operations were performed at hospitals considered to be large based on their bed size (86.8%), while only 6.8% of DBS operations were performed in medium-sized hospitals and only 5.4% were performed in small hospitals. The percent of PD patients admitted for DBS in medium-sized hospitals increased from 0.6% in 2000 to 8.9% in 2011 and in small hospitals from 1.4% to 11.7% over the same time frame (Figure 9) . However, these increases demonstrated relatively large year-to-year variability.
The majority of DBS operations were performed at urban hospitals (97.5%). More procedures were performed in the geographic Southern (35.5%) and Western (32.6%) United States compared to the Northeast (13.7%) and Midwest (18.3%) United States. Most DBS operations were performed in teaching hospitals (86.3%). Additionally, the proportion of PD patients admitted for DBS increased much more dramatically in teaching hospitals (13.3% in 2000 to 38.0% in 2011) compared to nonteaching hospitals (1.2% in 2000 to 3.1% in 2011; Figure 10 ). Of the patients admitted for PD who received DBS, 18.3% were from hospitals in the Midwest, 13.7% were from the Northeast, 35.5% were from the South, and 32.6% were from the West (Figure 11) . Also, of patients admitted for PD who received DBS, 1.48% were from rural hospitals while 97.5% were from urban hospitals (Tables 1 and 2 ; Figure 12 ).
The length of stay for a DBS admission (2.17 ± 0.14) was, on average, shorter than that for an admission for any other reason 
DISCUSSION
DBS is a mainstay for PD therapy. Usually, surgical intervention is used in the later stages of the disease after medical treatment has demonstrated reduced effectiveness. It has been well-demonstrated that neurostimulation is superior to medical therapy in reducing motor disability and improving daily functioning of Parkinson patients. 15, 17, [27] [28] [29] [30] [31] Medical therapy also carries with it significant motor complications, mood disturbances, and other psychiatric side effects. 14, 15, [32] [33] [34] [35] Very notably, recent literature suggests that DBS is more effective when used in patients with early manifestations of the disease. 16 Conversely, recent data suggest that surgical intervention done at later age NEUROSURGERY VOLUME 83 | NUMBER 6 | DECEMBER 2018 | E247 The quantified changes in the characteristics of the PD patients who received DBS are shown. yields poorer improvement in symptoms after surgery. 36 In this current project, we examined trends in neurosurgical intervention for PD. Specifically, the changes in the use of DBS over time identified in this study might be indicative of a change in physician perception of the utility of DBS for PD or of physicians suggesting DBS earlier for their PD patients. Importantly, we sought to identify whether there were any socioeconomic or hospital-based disparities in these trends that might influence future allocation of resources to provide more equitable care.
Our data suggested that, while there was a significant increase in DBS operations done over time for all patients overall, the number of operations for African-American patients showed a markedly stunted increase compared to non-African-American patients. Therefore, while it is true that physicians are operating on an increasing proportion of PD patients, this increase is not enjoyed by African-American patients. As such, if there is indeed a benefit afforded to patients who receive DBS earlier or more easily, African-American patients are not receiving that benefit. Moreover, African-American patients remained significantly less likely to receive DBS for their disease throughout the years studied. These disparities could arise due to a variety of reasons. First, African-American patients may belong to communities with decreased access to medical care, and thus are less likely to be aware of DBS as a potential treatment option. 37, 38 As such, community-specific steps can be taken to increase patient education in these populations and increase patient awareness of DBS as an option, to help eliminate a potential cause of DBS disparity seen in this population. [39] [40] [41] Similarly, throughout the decade studied, women with PD remained less likely to receive DBS. To date, no studies have conclusively demonstrated that DBS is less safe or effective in women. One possible explanation for this discrepancy is that women have less severe disease, secondary to the protective effects of estrogen. [42] [43] [44] [45] This protective effect is more pronounced in women undergoing estrogen replacement therapy. 44, 46, 47 Accordingly, if women, on average, demonstrate less severe disease presentations, physicians may be more willing to opt for conservative, medical management, rather than recommending DBS intervention. Regardless, this effect does not speak to whether women would benefit more from DBS earlier rather than later.
Consistent with literature that demonstrates decreased efficacy of DBS in older patients, patients older than 80 yr comprised only 3.1% of DBS operations despite comprising 34.3% of the PD disease burden. 36 However, the reduced proportion of DBS in older patients could be attributed to decreased viability of these patients as safe surgical candidates. Increased comorbidities may complicate the decision to operate on these patients. Thus, it is not necessarily the case that physicians as a whole believe that the DBS procedure itself is less effective in older patients in addressing PD symptoms. While most surgeries were performed on patients with limited comorbidities (CCI score of 0), our data suggest that physicians are becoming more comfortable performing DBS in patients with comorbid conditions that they might have previously considered poor surgical candidates. This could be due to increased understanding of the efficacy of DBS as well as improved operating room procedures that minimize risk of complications even in those with preexisting health conditions. Moreover, PD patients admitted for DBS demonstrated a more pronounced increase in teaching hospitals compared to nonteaching hospitals. This change could be due to a multitude of reasons pertaining to increased comfort and experience with DBS among academically oriented physicians. These physicians may be more willing to offer DBS, or offer the surgery earlier to their PD patients. Moreover, larger academic centers may be more likely to have the trained staff necessary to conduct a larger volume of DBS operations. More research should be conducted to analyze possible factors such as cost and personnel that might influence how often hospitals and practitioners recommend DBS to their patients.
Limitations
This study was subject to several limitations. Individual hospital policies, techniques, and patient demographics were not controlled. Variables analyzed while trending the usage of DBS were not stratified to identify possible confounding factors, and multivariate analysis was not performed. Due to possible complications of surgery, it is possible that an individual patient receiving DBS might have been admitted more than just one time although the surgery code would only be used for one of those admissions. Additionally, those with poorly controlled PD may have been admitted several times prior to receiving DBS. Because other indications for DBS exist, such as essential tremor, it is possible that some patients receiving DBS surgery were receiving it for an indication other than a pre-existing diagnosis of PD. Our estimation of the likelihood of a patient receiving DBS was based on whether a patient admitted with PD was admitted for a DBS procedure or for another reason. Thus, our analysis only estimates of the proportion of a population of PD patients receiving DBS, as patients who were not admitted were not included in analysis.
Coding accuracy and completeness of data entry may have also altered the results of this study.
CONCLUSION
Despite these limitations, our study estimates several important trends in the usage of DBS for PD. We found that several demographic variables influenced the trend in DBS surgery between 2000 and 2011. Identifying trends in usage can help to ensure that different demographic groups are fairly represented in the implementation and spread of new technology. Additionally, our study yielded hospital-related information to identify where DBS is performed, important for the future analysis of healthcare cost and delivery. Future retrospective and prospective studies should further stratify data to attempt to relate discrepancies in DBS surgery allocation to demographic variables, such as cultural beliefs, health status of the patient, and socioeconomic factors.
